Get our free guides
How VERIF.i® Offers Biopharma Researchers and Suppliers a Solution for On-site Supplier Pre-Assessments Both During and After the Pandemic
Perspectives from an Experienced Quality Auditor
Supplier pre-assessments are a headache for biopharma companies and suppliers alike. Despite being a critical part of the R&D lifecycle, they're often taxing to plan, expensive to manage, and an excessively time-consuming chunk of R&D project schedules. A global pandemic has only amplified all of these challenges.
Scientist.com is taking a huge step to solving all of these problems by standardizing physical lab inspections that evaluate the facilities, personnel, and processes supporting the sourcing of regulated services through its new VERIF.i supplier pre-assessment program.
- Researchers can proactively pre-assess suppliers without stepping on-site.
- Suppliers can save time, cost, and resources hosting repetitive audits and differentiate themselves within the market.
These two free guides, developed in partnership with Scientist.com, clearly and concisely unpack the advantages for each side from the perspective of an experienced third-party auditor. You'll learn exactly what you stand to gain from streamlining your pre-assessment program whether you're a researcher or a supplier.
About the Contributor
Brian Dense brings over 25 years of industry experience, with more than 20 years working directly in quality systems and assessing compliance with FDA 21 CFR Part 820, Parts 210 & 211, Part 58, ISO 13485, and ISO 9000.
Brian is skilled in implementing, managing
and maintaining complete quality systems to meet FDA regulations and ISO 9000 and ISO 13485 standards as well as regional and international supplier auditing, supplier controls, nonconforming product, complaint handling, and investigation and corrective and preventive action (CAPA).
Access and download both free guides and get everything you need to improve your pre-assessment program 👇